RN
Richard N Kender
DELAYED 1 MONTH
Director, Interim Chief Executive Officer
Seres Therapeutics, Inc.
Filings
1
Companies
1
Latest
Mar 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.
Richard N Kender
Director, Interim Chief Executive Officer
Filings
1
Companies
1
Latest
Mar 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.